Skip to content
Fiscal Receipts

Senate LDA lobbying filing

CARDINAL HEALTH INC

Registrant: CARDINAL HEALTH, INC. Year: 2024 Period: First Quarter Type: Q1

View on lda.senate.gov ↗

Reported income

not reported

Reported expenses

$480.0K

Tracked program mentions2

Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.

  • Emergency Management Modernization Program9666BU8000matched: “Emergency|Modernizationmatched 2+ title words

    Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization (H.R. 4421): to reauthorize certain programs under…

  • Making, Maintaining, Supply Chain and Logistics0602025Ematched: “Supply|Chainmatched 2+ title words

    Drug Supply Chain Security Act (DSCSA); Education on supply chain issues, raw material shortages, drug shortages…

Lobbying activities7

  • Civil Rights/Civil LibertiesCIV

    DE+I issues including the Equality Act

  • Disaster Planning/EmergenciesDIS

    Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization (H.R. 4421): to reauthorize certain programs under the Public Health Service Act with respect to public health security and all-hazards preparedness and response related to the Administration for Strategic Preparedness and Response, and for other purposes; fast pass for critical cargo (H.R. 6140 Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation Act); , provider relief, workforce shortages, pandemic preparedness, and product shortages

  • Energy/NuclearENG

    Nuclear shortage issues and Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 (H.R. 1199)

  • Health IssuesHCR

    Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, and DIR fees; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; Hospital Inpatient Services Modernization Act; Appropriations report language requests in support of the Food As Medicine initiative and examining drug shortages policies; Cybersecurity in healthcare; Issues related to cybersecurity attacks and the effects on pharmacy; Tax Relief for American Families and Workers Act of 2024 (H.R.7024).

  • ManufacturingMAN

    Drug Supply Chain Security Act (DSCSA); Education on supply chain issues, raw material shortages, drug shortages, ports and transportation issues, Buy America, domestic manufacturing, medical device sterilization; Stop Drug Shortages Act; Supply chain issues and delays related to US border crossings; Issues related to the medical supply chain and transportation bottlenecks.

  • Tariff (miscellaneous tariff bills)TAR

    Exclusion of health care related products in section 301 tariffs

  • Taxation/Internal Revenue CodeTAX

    Tax Relief for American Families and Workers Act of 2024 (H.R.7024)

Lobbyists4

  • ABIGAIL BARNES
  • ANGELEINE COMTE
  • JERRICA MATHIS
  • REBECCA MCGRATH

Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.